"Cynata's technology came about after bone-marrow derived technologies, so naturally they are not as far down the road, relatively speaking. However, it doesn't mean that Cynata will not continue to advance the technology in a clinical setting and increase the value in the short and long term."
So you acknowledge 1. CYP is well behind 2. Cynata are in a petri dish stage 3. Cynata have no contemplation or considerations for a manufacturing facility
CYP Price at posting:
31.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)